Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trialArticle Published on 2022-10-132022-11-15 Journal: eLife [Category] [DOI] 10.7554/eLife.81477 PMC 바로가기
Differential vaccine-induced kinetics of humoral and cellular immune responses in SARS-CoV-2 naive and convalescent health care workersArticle Published on 2022-10-032022-11-15 Journal: Pathogens and disease [Category] [DOI] 10.1093/femspd/ftac035 PMC 바로가기
NVX-CoV2373 vaccination induces functional SARS-CoV-2-specific CD4+ and CD8+ T cell responsesArticle Published on 2022-10-032022-11-15 Journal: The Journal of Clinical Investigation [Category] [DOI] 10.1172/JCI160898 PMC 바로가기
Protein vaccine NVX-CoV2373 elicits functional T cell immunityArticle Published on 2022-10-032022-11-15 Journal: The Journal of Clinical Investigation [Category] [DOI] 10.1172/JCI163614 PMC 바로가기
COVID-19 vaccine type-dependent differences in immunogenicity and inflammatory response: BNT162b2 and ChAdOx1 nCoV-19Article Published on 2022-09-022022-11-15 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.975363 PMC 바로가기
Humoral and Cellular Immune Responses to Vector, Mix-and-Match, or mRNA Vaccines against SARS-CoV-2 and the Relationship between the Two Immune ResponsesArticle Published on 2022-08-312022-11-15 Journal: Microbiology Spectrum [Category] [DOI] 10.1128/spectrum.02495-21 PMC 바로가기
Efficacy of BCG Vaccination Against Respiratory Tract Infections in Older Adults During the Coronavirus Disease 2019 PandemicRandomized Controlled Trial Published on 2022-08-242022-10-04 Journal: Clinical Infectious Diseases: An Official Publicat [Category] [DOI] 10.1093/cid/ciac182 PMC 바로가기 [Article Type] Randomized Controlled Trial
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for an inactivated viral vaccine against Chikungunya virusChikungunya 바이러스에 대한 비활성화된 바이러스 백신의 이점/위험 평가에 대한 주요 고려 사항이 포함된 Brighton Collaboration 표준화 템플릿Clinical Trial Published on 2022-08-192022-09-12 Journal: Vaccine [Category] [DOI] 10.1016/j.vaccine.2022.06.006 PMC 바로가기 [Article Type] Clinical Trial
Durability of Heterologous and Homologous COVID-19 Vaccine Boosts이종 및 동종 COVID-19 백신의 내구성 향상Article Published on 2022-08-012022-09-11 Journal: JAMA Network Open [Category] [DOI] 10.1001/jamanetworkopen.2022.26335 PMC 바로가기 [Article Type] Article
Immunogenicity of candidate SARS-CoV-2 DNA vaccines based on the spike protein스파이크 단백질을 기반으로 한 후보 SARS-CoV-2 DNA 백신의 면역원성Article Published on 2022-08-012022-09-12 Journal: Virology [Category] [DOI] 10.1016/j.virol.2022.06.006 PMC 바로가기 [Article Type] Article